Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Asthma Therapeutics Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Drug Class (Anti-inflammatory, Combination Therapy, Bronchodilators)
4.2.2. By Product (Inhalers (Dry powder inhalers, Metered dose inhalers, Soft mist inhalers), Nebulizers)
4.2.3. By Route of Administration (Oral, Inhaled, Others)
4.2.4. By Region
4.2.5. By Company (2023)
4.3. Market Map
4.3.1. By Drug Class
4.3.2. By Product
4.3.3. By Route of Administration
4.3.4. By Region

5. Asia Pacific Asthma Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class
5.2.2. By Product
5.2.3. By Route of Administration
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Asthma Therapeutics Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Drug Class
5.3.1.2.2. By Product
5.3.1.2.3. By Route of Administration
5.3.2. India Asthma Therapeutics Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Drug Class
5.3.2.2.2. By Product
5.3.2.2.3. By Route of Administration
5.3.3. Australia Asthma Therapeutics Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Drug Class
5.3.3.2.2. By Product
5.3.3.2.3. By Route of Administration
5.3.4. Japan Asthma Therapeutics Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Drug Class
5.3.4.2.2. By Product
5.3.4.2.3. By Route of Administration
5.3.5. South Korea Asthma Therapeutics Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Drug Class
5.3.5.2.2. By Product
5.3.5.2.3. By Route of Administration

6. Europe Asthma Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Product
6.2.3. By Route of Administration
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Asthma Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Product
6.3.1.2.3. By Route of Administration
6.3.2. Germany Asthma Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Product
6.3.2.2.3. By Route of Administration
6.3.3. Spain Asthma Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Product
6.3.3.2.3. By Route of Administration
6.3.4. Italy Asthma Therapeutics Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Drug Class
6.3.4.2.2. By Product
6.3.4.2.3. By Route of Administration
6.3.5. United Kingdom Asthma Therapeutics Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Drug Class
6.3.5.2.2. By Product
6.3.5.2.3. By Route of Administration

7. North America Asthma Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Product
7.2.3. By Route of Administration
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Asthma Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Product
7.3.1.2.3. By Route of Administration
7.3.2. Mexico Asthma Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Product
7.3.2.2.3. By Route of Administration
7.3.3. Canada Asthma Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Product
7.3.3.2.3. By Route of Administration

8. South America Asthma Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Product
8.2.3. By Route of Administration
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Asthma Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Product
8.3.1.2.3. By Route of Administration
8.3.2. Argentina Asthma Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Product
8.3.2.2.3. By Route of Administration
8.3.3. Colombia Asthma Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Product
8.3.3.2.3. By Route of Administration
9. Middle East and Africa Asthma Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Product
9.2.3. By Route of Administration
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Asthma Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Product
9.3.1.2.3. By Route of Administration
9.3.2. Saudi Arabia Asthma Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Product
9.3.2.2.3. By Route of Administration
9.3.3. UAE Asthma Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Product
9.3.3.2.3. By Route of Administration
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Asthma Therapeutics Market: SWOT Analysis

13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape
14.1. Teva Pharmaceutical Industries Ltd.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. GSK plc.
14.3. Merck& Co., Inc.
14.4. F. Hoffmann-La Roche Ltd
14.5. AstraZeneca plc
14.6. Boehringer Ingelheim International GmbH.
14.7. Sanofi S.A.
14.8. Koninklijke Philips N.V.
14.9. Becton, Dickinson and Company
14.10. Sunovion Pharmaceuticals, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer